Medvix Publications
Medvix Publications is committed to upholding the highest standards of research integrity, ethical publishing, and transparency. This policy applies to all journals published by Medvix Publications and is guided by the principles of the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE), and other recognized international guidelines.
All research involving human participants must receive approval from an appropriate Institutional Review Board (IRB) or Ethics Committee.
Authors must clearly state the name of the ethics committee and approval reference number in the manuscript.
Informed consent must be obtained from all participants, and privacy and confidentiality must be protected.
Studies involving animals must comply with institutional, national, or international animal care and use guidelines.
Research must be conducted honestly, responsibly, and transparently.
Authorship should reflect substantial scholarly contribution to the conception, design, data acquisition, analysis, or interpretation of the study.
All listed authors must approve the final manuscript before submission.
Any changes to authorship after submission require written consent from all authors.
Contributors who do not meet authorship criteria must be acknowledged appropriately.
Authors, editors, and reviewers must disclose any financial, personal, or institutional conflicts of interest.
If no conflicts exist, authors must state:
“The authors declare no conflict of interest.”
Fabrication, falsification, selective reporting, or manipulation of data is strictly prohibited.
Authors may be requested to provide raw data or supporting documentation for editorial review.
Data sharing is encouraged to promote reproducibility and transparency in research
5. Corrections (Errata)
A correction will be issued when errors are identified that do not invalidate the study’s findings, such as:
Typographical or formatting errors
Incorrect author names or affiliations
Minor data or figure errors
Corrections will be:
Clearly labeled and linked to the original article
Freely accessible
Permanently available and citable
An article may be retracted if:
Findings are unreliable due to misconduct or honest error
Plagiarism or duplicate publication is confirmed
Ethical approval or informed consent was not obtained
Data fabrication or falsification is discovered
Retraction notices will:
Clearly state the reason for retraction
Remain permanently linked to the original article
Not remove the article, but mark it clearly as Retracted
An Editorial Expression of Concern may be issued when:
Serious ethical or scientific concerns have been raised
An investigation is ongoing or unresolved
Evidence is inconclusive, or institutional responses are delayed
This ensures transparency while investigations are completed.
Authors may appeal editorial decisions by submitting a written explanation and supporting evidence.
All investigations are conducted confidentially, fairly, and objectively.
Final decisions rest with the Editor-in-Chief in line with ethical standards.
Medvix Publications is responsible for maintaining the integrity of the scholarly record. All corrections, retractions, and expressions of concern are handled transparently and in accordance with international ethical guidelines.